Why Medical Weight Loss Clinic (GLP-1/Semaglutide)s Choose Surveys & Feedback Calls

{"faqs":[{"answer":"You buy campaigns that we run for you — no per-seat charges, no platform bill, no minimums you didn't choose. Calling starts at 9¢ per connected minute, tiered by volume, with the rate locked for the campaign. Your staff stays focused on patients in the office while structured survey calls run in approved windows against your permissioned list, with every outcome reported honestly.","question":"Why use a managed calling service instead of hiring more front-desk staff for patient outreach?"}],"steps":[{"step":"1","title":"Define the Survey Goal","gradient":"from-orange-500 to-red-500","description":"Start with one question: what do you need the call to accomplish? We scope the campaign around a single outcome — like measuring patient satisfaction or identifying refill concerns — and quote the whole campaign before it launches."},{"step":"2","title":"Review List, Script, and Approve","gradient":"from-yellow-500 to-orange-500","description":"We review your patient list source, consent records, and calling windows, then build the survey script, disclosure, opt-out handling, and escalation path. Nothing launches until you approve."},{"step":"3","title":"Launch and Get Real Outcomes","gradient":"from-green-500 to-emerald-500","description":"Calls run in approved windows and outcomes are monitored in real time. You receive a dispositioned contact list, outcome counts, routed follow-ups, and a completion report — with hot concerns transferred live or landed in your CRM."}],"ctaText":"Plan My Campaign — Managed survey calls for your approved patient list, from 9¢ per connected minute. First campaign review is free.","eyebrow":"Surveys & Feedback Calls","benefits":[{"icon":"Headphones","title":"Reach Every Patient on Your List","gradient":"from-emerald-500 to-teal-500","description":"Structured survey calls run in approved calling windows against your permissioned patient list, so feedback collection between titration visits no longer depends on spare front-desk minutes. Whether you're checking in on patients adjusting to a new semaglutide dose or surveying a cash-pay concierge cohort, every call runs with AI disclosure, keyword opt-outs (STOP and REVOKE), and quiet-hours compliance built in — critical when GLP-1 use among diagnosed diabetics reached 26.5% in 2024 (CDC NCHS Data Brief).","proof_point":"GLP-1 use among adults with diagnosed diabetes reached 26.5% in 2024, peaking at 33.3% for ages 50-64 (CDC NCHS Data Brief) — the patient population needing structured follow-up keeps expanding."},{"icon":"CheckCircle","title":"Know What Actually Happened","gradient":"from-green-500 to-blue-500","description":"Every survey campaign ends with a named outcome report: disposition codes (confirmed, qualified, renewed, opted out, no answer), per-call notes, a dispositioned contact list, completion and coverage report, and opt-out and DNC logs. You see exactly how many GLP-1 patients reported side-effect concerns, titration questions, or refill issues — and we report what actually happened. No invented numbers, no inflated response rates.","proof_point":"Deliverables on every campaign: dispositioned contact list, outcome counts, routed follow-ups, completion/coverage report, and opt-out and DNC logs."},{"icon":"Zap","title":"Catch At-Risk Patients Before They Cancel","gradient":"from-cyan-400 to-purple-400","description":"Survey responses and follow-up requests route back into your CRM and scheduling tools in real time, so concerns about titration discomfort, side effects, or program fit surface early — before the patient cancels. Hot leads transfer to your team live or land in your CRM, protecting recurring-revenue patients in a GLP-1 market projected to grow from USD 48.6 billion in 2026 to USD 156.4 billion by 2036 (Fact.MR).","proof_point":"Fact.MR projects the GLP-1 market growing from USD 48.6 billion in 2026 to USD 156.4 billion by 2036 — retention of existing patients is the cheapest growth available."}],"features":["Surveys & Feedback campaigns with one clear goal per campaign, scoped and quoted before launch.","List and consent review before any campaign — list source and consent records checked, and we tell you plainly if a list won't work before you spend anything.","Script, disclosure, opt-out handling, and escalation path built for your approval — nothing launches until you sign off.","Named outcome report with disposition codes, per-call notes, routed follow-ups, and completion and coverage reports.","Calling starts at 9¢ per connected minute, tiered by volume — no per-seat charges, no platform bill, no unchosen minimums.","Hot follow-up requests transfer to your team live or land in your CRM and scheduling tools automatically."],"headline":"Hear From Every GLP-1 Patient — Without Drowning Your Front Desk","problems":[{"icon":"PhoneMissed","stat":"8% of all prescriptions","color":"from-red-500 to-pink-500","title":"GLP-1 Adherence Slips Away in Silence Between Visits","description":"Patients on semaglutide and tirzepatide titration schedules often go quiet between follow-up visits, and medication adherence and refill workflows demand ongoing outreach your front desk can't sustain. With GLP-1s accounting for nearly 8% of all prescriptions filled in early 2026, the population needing check-ins is growing faster than clinic capacity — and every patient who drifts off their titration schedule without a call represents lost recurring revenue in a physician supervised weight loss program."},{"icon":"Clock","stat":"Ongoing oversight required","color":"from-orange-500 to-yellow-500","title":"Side Effects and Refill Concerns Go Unheard Until Patients Churn","description":"Patients on GLP-1 receptor agonists frequently need to raise side effects, titration questions, and refill issues that require ongoing medical oversight — but when inbound call volume overwhelms front-desk staff, those concerns never surface until the patient quietly cancels their cash-pay concierge membership. By the time you hear about nausea during dose escalation or a missed refill, the patient has already decided your weight loss clinic isn't responsive enough to justify the monthly spend."},{"icon":"TrendingUp","stat":"500%+ spending growth","color":"from-red-500 to-pink-500","title":"A Booming GLP-1 Market You Can't Afford to Lose Patients In","description":"Spending on GLP-1s rose more than 500% from 2018 to 2023, from $13.7 billion to $71.7 billion (JAMA Network Open), with Ozempic alone growing from $410 million to $26.42 billion over that period. Competition for BMI-eligible patients is intensifying, and every recurring-revenue patient who leaves your semaglutide program without giving feedback represents significant lost lifetime patient value — churn you might have prevented with one structured feedback call."}],"quickWins":["Run a Compliance & Health Check-In campaign against your permissioned patient list to catch titration and side-effect concerns between visits — every follow-up request routed into your CRM in real time.","Pair your survey campaign with Appointment & Event Reminders (same-day, day-before, or multi-touch windows) to cut no-shows for GLP-1 follow-up visits and refill consultations."],"subheadline":"My AI Call Center runs managed survey and feedback calls against your approved patient lists, so your medical weight loss clinic learns how patients are really doing on semaglutide — from 9¢ per connected minute.","problemTitle":"The Feedback Gap Quietly Undermining GLP-1 Clinics","testimonials":[{"quote":"Our semaglutide patients needed check-ins between titration visits, but we had no staff hours to spare. My AI Call Center ran a structured survey campaign against our permissioned patient list, and every response came back with disposition codes and per-call notes routed straight into our CRM. We finally hear about side-effect concerns before patients cancel.","title":"Medical Director","author":"Dr. Priya Raghavan","business_type":"Medical Weight Loss Clinic (GLP-1/Semaglutide)"},{"quote":"What sold us was the list discipline. They reviewed our consent records before launch and told us plainly which parts of our patient list wouldn't support the campaign. Nothing launched until we approved the script, disclosure, and escalation path — which matters when you're running HIPAA-sensitive outreach.","title":"Clinic Operations Manager","author":"Marcus Delgado","business_type":"Medical Weight Loss Clinic (GLP-1/Semaglutide)"},{"quote":"The rate was locked for the whole campaign and the outcome report showed exactly what happened — confirmed, no answer, opted out. No invented numbers, just real dispositions we could act on. When a GLP-1 patient flagged a titration concern, the follow-up request landed with our team the same day.","title":"Owner","author":"Sandra Whitfield","business_type":"Medical Weight Loss Clinic (GLP-1/Semaglutide)"}],"whyDifferent":["Managed service, not software — you buy campaigns that we run for you.","Only approved, permissioned, or reviewed lists — never indiscriminate cold calling.","One clear goal per campaign, quoted before launch.","Rate locked for the campaign — never moves mid-flight.","We report what actually happened — no invented metrics or testimonials.","AI disclosure on every call; opt-outs logged and honored immediately.","Outcomes route into the CRM and scheduling tools you already run.","HIPAA-compliant communication standards on clinic campaigns."],"benefitsTitle":"Why GLP-1 Clinics Choose My AI Call Center for Patient Feedback","solutionTitle":"How My AI Call Center Closes the Feedback Loop for GLP-1 Clinics","internal_links":null,"solutionPoints":["One clear goal per survey campaign, quoted in full before launch — no mid-campaign surprises.","Outcomes, follow-up requests, and patient concerns route back into the CRM and scheduling tools you already run.","HIPAA-compliant communication standards, AI disclosure on every call, and opt-outs logged and honored immediately."],"socialProofText":"Owned and operated by AIQ Labs — based in Halifax, Nova Scotia with a US operating base in Austin, Texas. We report what actually happened: no invented client logos, testimonials, metrics, or ratings.","problemHighlight":"Patient Retention Blind Spots","solutionSubtitle":"Managed survey and feedback calls that reach your approved patient lists, capture real responses, and route what matters back to your team.","headlineHighlight":"Every Patient","research_keywords":["semaglutide near me","GLP-1 doctor near me","weight loss clinic near me","medical weight loss program","semaglutide weight loss clinic","GLP-1 for weight loss","Ozempic doctor prescription","Wegovy prescription online","tirzepatide weight loss clinic","medical weight loss doctor","GLP-1 clinic [city]","semaglutide cost without insurance","physician supervised weight loss","GLP-1 weight loss treatment","does insurance cover GLP-1 for weight loss"],"solutionDescription":"My AI Call Center is a done-for-you managed outbound calling service — you buy campaigns that we run for you. For a GLP-1 or semaglutide weight loss clinic, a Surveys & Feedback campaign has one clear goal: find out how patients are doing, what they need, and whether they plan to continue. We only call approved, permissioned, or reviewed contact lists, and we check list source and consent records before any campaign launches. Every call includes AI disclosure, keyword opt-outs are honored immediately, and outcomes arrive as a named outcome report with disposition codes, per-call notes, and follow-up requests routed straight into your CRM.","research_sources_count":11}